Biomea Fusion, Inc.
BMEA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840439
No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Biomea Fusion, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 73 | 90 | +17 |
| Shares | 23.4M | 29.6M | +6.14M (+26.2%) |
| Value | $727.0M | $649.4M | −$77.6M (−10.7%) |
New holders (37)
Institutions that held Biomea Fusion, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (20)
Institutions that held Biomea Fusion, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Maven Securities LTD | 114,354 | $3.55M |
| Monashee Investment Management LLC | 90,000 | $2.79M |
| Renaissance Technologies LLC | 79,800 | $2.48M |
| EAM Investors, LLC | 78,391 | $2.43M |
| HRT Financial LP | 75,510 | $2.34M |
| CVI Holdings, LLC | 70,000 | $2.17M |
| Belvedere Trading LLC | 23,457 | $727.4K |
| Ergoteles LLC | 17,000 | $527.2K |
| Fred Alger Management, LLC | 16,689 | $517.5K |
| Simplex Trading, LLC | 15,299 | $474.0K |
| SEI Investments Co | 12,705 | $394.0K |
| Marshall Wace, LLP | 10,776 | $334.2K |
| Sandia Investment Management LP | 10,000 | $310.1K |
| Diametric Capital, LP | 8,338 | $258.6K |
| Chartwell Investment Partners, LLC | 8,311 | $258.0K |
| Raymond James Financial Services Advisors, Inc. | 7,982 | $247.5K |
| Balyasny Asset Management LLC | 7,695 | $238.6K |
| High Net Worth Advisory Group LLC | 7,500 | $232.6K |
| Crewe Advisors LLC | 337 | $10.5K |
| Ellevest, Inc. | 275 | $8.53K |